Breaking News Instant updates and real-time market news.

2020-11-20 14:41:51 JNJ Johnson & Johnson $146.76 / -0.33 (-0.22%) , LLY Eli Lilly $145.42 / +1.96 (+1.37%) … 14:41 11/20/20 11/20 14:41 11/20/20 14:41	Trump announces new actions intended to limit drug prices President Donald Trump is discussing two new executive actions aimed at limiting drug prices in a press conference from the White House. Publicly traded drugmakers include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY). JNJ Johnson & Johnson $146.76 / -0.33 (-0.22%) LLY Eli Lilly $145.42 / +1.96 (+1.37%) MRK Merck $80.68 / +0.26 (+0.32%) PFE Pfizer $36.85 / +0.66 (+1.82%) SNY Sanofi $50.55 / -0.26 (-0.51%) AZN AstraZeneca $55.09 / +1.07 (+1.98%) GSK GlaxoSmithKline $37.03 / -0.11 (-0.30%) NVS Novartis $87.33 / +0.11 (+0.13%) RHHBY Roche $0.00 / + (+0.00%) BMY Bristol-Myers $61.96 / -0.135 (-0.22%)	23 Nov 23 Nov 05 Dec 15 Dec 15 Dec 15 Dec 24 Jan 26 Jan 29 Jan 04 Feb 20 Feb 27 Mar
JNJ LLY MRK PFE SNY AZN GSK NVS RHHBY BMY JNJ Johnson & Johnson $146.76 / -0.33 (-0.22%) 11/12/20 Chardan Immunovant price target raised to $60 from $45 at Chardan 11/10/20 Piper Sandler Aligos Therapeutics initiated with an Overweight at Piper Sandler 10/26/20 RBC Capital Morphic Holding initiated with an Outperform at RBC Capital 10/14/20 Credit Suisse Johnson & Johnson price target raised to $168 from $163 at Credit Suisse LLY Eli Lilly $145.42 / +1.96 (+1.37%) 11/17/20 Mizuho Eli Lilly price target lowered to $156 from $164 at Mizuho 11/10/20 Bernstein Eli Lilly initiated with a Market Perform, $150 price target at Bernstein 11/10/20 Bernstein Eli Lilly initiated with a Market Perform at Bernstein 11/10/20 SVB Leerink Regeneron price target lowered to $643 from $653 at SVB Leerink MRK Merck $80.68 / +0.26 (+0.32%) 11/10/20 Bernstein Bernstein bullish on Merck, initiates with an Outperform 11/10/20 Bernstein Merck initiated with an Outperform at Bernstein 11/02/20 Raymond James Jounce Therapeutics downgraded to Market Perform at Raymond James 10/23/20 Fly Intel: Pre-market Movers PFE Pfizer $36.85 / +0.66 (+1.82%) 11/19/20 Fly Intel: Top five analyst initiations 11/19/20 Goldman Sachs Pfizer reinstated with a Neutral at Goldman Sachs 11/17/20 Benchmark Inovio on 'top-10 vaccine contenders list,' says Benchmark 11/17/20 Maxim Co-Diagnostics price target lowered to $20 from $30 at Maxim SNY Sanofi $50.55 / -0.26 (-0.51%) 11/03/20 Morgan Stanley Sanofi price target lowered to EUR 105 from EUR 107 at Morgan Stanley 10/30/20 JPMorgan Sanofi price target lowered to EUR 100 from EUR 106 at JPMorgan 10/06/20 Raymond James Raymond James says FDA guidance 'likely assures' no vaccine EUA before late Nov. 10/04/20 Goldman Sachs Translate Bio initiated with a Buy at Goldman Sachs AZN AstraZeneca $55.09 / +1.07 (+1.98%) 11/11/20 Oppenheimer Amgen price target raised to $280 from $275 at Oppenheimer 11/11/20 HSBC AstraZeneca upgraded to Hold from Reduce at HSBC 11/11/20 HSBC AstraZeneca upgraded to Hold from Reduce at HSBC 10/23/20 Stifel FibroGen safety data mitigates concerns of roxadustat black box, says Stifel GSK GlaxoSmithKline $37.03 / -0.11 (-0.30%) 11/13/20 Morgan Stanley GlaxoSmithKline upgraded to Equal Weight from Underweight at Morgan Stanley 11/02/20 Liberum GlaxoSmithKline upgraded to Buy from Hold at Liberum 10/30/20 Barclays GlaxoSmithKline price target lowered to 1,300 GBp from 1,550 GBp at Barclays 10/27/20 Truist AnaptysBio price target raised to $27 from $20 at Truist NVS Novartis $87.33 / +0.11 (+0.13%) 11/10/20 JPMorgan Novartis price target raised to CHF 85 from CHF 82 at JPMorgan 10/26/20 JMP Securities Kura Oncology price target raised to $33 from $22 at JMP Securities 09/29/20 Berenberg Novartis initiated with a Buy at Berenberg 09/24/20 Barclays Regenxbio price target lowered to $79 from $88 at Barclays RHHBY Roche $0.00 / + (+0.00%) 11/11/20 Truist Opthea initiated with a Buy at Truist 10/16/20 UBS Roche price target lowered to CHF 370 from CHF 390 at UBS 10/06/20 Goldman Sachs Goldman reiterates $34 target on Kiniksa after 'impressive' data 09/29/20 Berenberg Roche initiated with a Hold at Berenberg BMY Bristol-Myers $61.96 / -0.135 (-0.22%) 11/17/20 Mizuho Bristol-Myers Squibb CVR price target lowered to $3.34 from $6.17 at Mizuho 11/16/20 Societe Generale Bristol-Myers upgraded to Buy from Hold at Societe Generale 11/10/20 Bernstein Bristol-Myers initiated with a Market Perform, $72 price target at Bernstein 11/10/20 Bernstein Bristol-Myers initiated with a Market Perform at Bernstein

2020-11-20 14:41:51

JNJ

Johnson & Johnson

$146.76 / -0.33 (-0.22%)

, LLY

Eli Lilly

$145.42 / +1.96 (+1.37%)

… 14:41

11/20/20

11/20

14:41

11/20/20

14:41

Trump announces new actions intended to limit drug prices

President Donald Trump is discussing two new executive actions aimed at limiting drug prices in a press conference from the White House. Publicly traded drugmakers include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY).

JNJ

Johnson & Johnson

$146.76 / -0.33 (-0.22%)

LLY

Eli Lilly

$145.42 / +1.96 (+1.37%)

MRK

Merck

$80.68 / +0.26 (+0.32%)

PFE

Pfizer

$36.85 / +0.66 (+1.82%)

SNY

Sanofi

$50.55 / -0.26 (-0.51%)

AZN

AstraZeneca

$55.09 / +1.07 (+1.98%)

GSK

GlaxoSmithKline

$37.03 / -0.11 (-0.30%)

NVS

Novartis

$87.33 / +0.11 (+0.13%)

RHHBY

Roche

$0.00 / + (+0.00%)

BMY

Bristol-Myers

$61.96 / -0.135 (-0.22%)

23
Nov
23
Nov
05
Dec
15
Dec
15
Dec
15
Dec
24
Jan
26
Jan
29
Jan
04
Feb
20
Feb
27
Mar

JNJ
LLY
MRK
PFE
SNY
AZN
GSK
NVS
RHHBY
BMY

JNJ Johnson & Johnson

$146.76 / -0.33 (-0.22%)

11/12/20 Chardan: Immunovant price target raised to $60 from $45 at Chardan

11/10/20 Piper Sandler: Aligos Therapeutics initiated with an Overweight at Piper Sandler

10/26/20 RBC Capital: Morphic Holding initiated with an Outperform at RBC Capital

10/14/20 Credit Suisse: Johnson & Johnson price target raised to $168 from $163 at Credit Suisse

LLY Eli Lilly

$145.42 / +1.96 (+1.37%)

11/17/20 Mizuho: Eli Lilly price target lowered to $156 from $164 at Mizuho

11/10/20 Bernstein: Eli Lilly initiated with a Market Perform, $150 price target at Bernstein

11/10/20 Bernstein: Eli Lilly initiated with a Market Perform at Bernstein

11/10/20 SVB Leerink: Regeneron price target lowered to $643 from $653 at SVB Leerink

MRK Merck

$80.68 / +0.26 (+0.32%)

11/10/20 Bernstein: Bernstein bullish on Merck, initiates with an Outperform

11/10/20 Bernstein: Merck initiated with an Outperform at Bernstein

11/02/20 Raymond James: Jounce Therapeutics downgraded to Market Perform at Raymond James

10/23/20: Fly Intel: Pre-market Movers

PFE Pfizer

$36.85 / +0.66 (+1.82%)

11/19/20: Fly Intel: Top five analyst initiations

11/19/20 Goldman Sachs: Pfizer reinstated with a Neutral at Goldman Sachs

11/17/20 Benchmark: Inovio on 'top-10 vaccine contenders list,' says Benchmark

11/17/20 Maxim: Co-Diagnostics price target lowered to $20 from $30 at Maxim

SNY Sanofi

$50.55 / -0.26 (-0.51%)

11/03/20 Morgan Stanley: Sanofi price target lowered to EUR 105 from EUR 107 at Morgan Stanley

10/30/20 JPMorgan: Sanofi price target lowered to EUR 100 from EUR 106 at JPMorgan

10/06/20 Raymond James: Raymond James says FDA guidance 'likely assures' no vaccine EUA before late Nov.

10/04/20 Goldman Sachs: Translate Bio initiated with a Buy at Goldman Sachs

AZN AstraZeneca

$55.09 / +1.07 (+1.98%)

11/11/20 Oppenheimer: Amgen price target raised to $280 from $275 at Oppenheimer

11/11/20 HSBC: AstraZeneca upgraded to Hold from Reduce at HSBC

11/11/20 HSBC: AstraZeneca upgraded to Hold from Reduce at HSBC

10/23/20 Stifel: FibroGen safety data mitigates concerns of roxadustat black box, says Stifel

GSK GlaxoSmithKline

$37.03 / -0.11 (-0.30%)

11/13/20 Morgan Stanley: GlaxoSmithKline upgraded to Equal Weight from Underweight at Morgan Stanley

11/02/20 Liberum: GlaxoSmithKline upgraded to Buy from Hold at Liberum

10/30/20 Barclays: GlaxoSmithKline price target lowered to 1,300 GBp from 1,550 GBp at Barclays

10/27/20 Truist: AnaptysBio price target raised to $27 from $20 at Truist

NVS Novartis

$87.33 / +0.11 (+0.13%)

11/10/20 JPMorgan: Novartis price target raised to CHF 85 from CHF 82 at JPMorgan

10/26/20 JMP Securities: Kura Oncology price target raised to $33 from $22 at JMP Securities

09/29/20 Berenberg: Novartis initiated with a Buy at Berenberg

09/24/20 Barclays: Regenxbio price target lowered to $79 from $88 at Barclays

RHHBY Roche

$0.00 / + (+0.00%)

11/11/20 Truist: Opthea initiated with a Buy at Truist

10/16/20 UBS: Roche price target lowered to CHF 370 from CHF 390 at UBS

10/06/20 Goldman Sachs: Goldman reiterates $34 target on Kiniksa after 'impressive' data

09/29/20 Berenberg: Roche initiated with a Hold at Berenberg

BMY Bristol-Myers

$61.96 / -0.135 (-0.22%)

11/17/20 Mizuho: Bristol-Myers Squibb CVR price target lowered to $3.34 from $6.17 at Mizuho

11/16/20 Societe Generale: Bristol-Myers upgraded to Buy from Hold at Societe Generale

11/10/20 Bernstein: Bristol-Myers initiated with a Market Perform, $72 price target at Bernstein

11/10/20 Bernstein: Bristol-Myers initiated with a Market Perform at Bernstein

TODAY'S FREE FLY STORIES

Hot Stocks	OraSure's saliva collection device authorized by Health Canada for COVID-19 test » 06:19 01/28/21 01/28 06:19 01/28/21 06:19 OSUR OraSure $13.93 / -0.24 (-1.69%) OraSure's OMNIgene… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options OSUR OraSure $13.93 / -0.24 (-1.69%) 01/26/21 Chronomics selects OraSure's OMNIgene ORAL salive collection kit 01/21/21 OraSure's saliva collection kit Included in FDA authorization for exome platform 12/23/20 OraSure's OMNIgene device included in EUA amendment of SARS-CoV-2 test 12/21/20 OraSure provides update on EUA SARS-CoV-2 antibody test OSUR OraSure $13.93 / -0.24 (-1.69%) 12/22/20 Lake Street Lake Street says OraSure test news disappointing, not due to fundamental issues 08/21/20 Fly Intel: Top five analyst initiations 08/21/20 Evercore ISI OraSure initiated with an Outperform at Evercore ISI 08/21/20 Evercore ISI OraSure initiated with an Outperform at Evercore ISI OSUR OraSure $13.93 / -0.24 (-1.69%) 11/04/20 OraSure reports Q EPS 1c, consensus (7c) 08/05/20 OraSure reports Q EPS (16c), consensus (9c) 03 Jun OSUR OraSure $13.93 / -0.24 (-1.69%) 12/23/20 Fly Intel: Pre-market Movers 11/04/20 Fly Intel: After-Hours Movers 10/19/20 Fly Intel: Pre-market Movers 08/06/20 Fly Intel: Wall Street's top stories for Thursday OSUR OraSure $13.93 / -0.24 (-1.69%) 11/04/20 OraSure options imply 19.8% move in share price post-earnings
Downgrade	Arcos Dorados downgraded to Neutral from Outperform at Bradesco BBI » 06:19 01/28/21 01/28 06:19 01/28/21 06:19 ARCO Arcos Dorados / + Bradesco BBI analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Options ARCO Arcos Dorados / + 07/02/20 Bradesco BBI Arcos Dorados upgraded to Outperform from Neutral at Bradesco BBI 06/26/20 Morgan Stanley Arcos Dorados initiated with an Overweight at Morgan Stanley ARCO Arcos Dorados / + 12/18/20 Unusually active option classes on open December 18th
Downgrade	MercadoLibre downgraded to Neutral from Outperform at Bradesco BBI » 06:18 01/28/21 01/28 06:18 01/28/21 06:18 MELI MercadoLibre $1,717.45 / -90.29 (-4.99%) Bradesco BBI analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options MELI MercadoLibre $1,717.45 / -90.29 (-4.99%) 01/07/21 MercadoLibre announces repurchase of $440M convertible senior notes 11/24/20 Amazon Web Services selected by MercadoLibre as primary cloud provider 08/04/20 MercadoLibre changes release date of Q2 results MELI MercadoLibre $1,717.45 / -90.29 (-4.99%) 01/27/21 Deutsche Bank MercadoLibre price target raised to $2,200 from $1,530 at Deutsche Bank 01/20/21 Citi MercadoLibre price target raised to $2,150 from $1,300 at Citi 01/19/21 HSBC MercadoLibre price target raised to $2,100 from $1,800 at HSBC 01/04/21 Barclays MercadoLibre assumed with an Overweight at Barclays MELI MercadoLibre $1,717.45 / -90.29 (-4.99%) 11/04/20 MercadoLibre reports Q3 EPS 28c, consensus 17c 08/10/20 MercadoLibre reports Q2 EPS $1.11, consensus 2c MELI MercadoLibre $1,717.45 / -90.29 (-4.99%) 11/04/20 Fly Intel: After-Hours Movers 08/11/20 Honeywell downgrade among today's top calls on Wall Street MELI MercadoLibre $1,717.45 / -90.29 (-4.99%) 08/31/20 MercadoLibre put volume heavy and directionally bearish
Periodicals	Intel invests a further $475M in Vietnam, DigiTimes reports » 06:18 01/28/21 01/28 06:18 01/28/21 06:18 INTC Intel $53.59 / -1.62 (-2.93%) Intel has invested a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options INTC Intel $53.59 / -1.62 (-2.93%) 01/27/21 Intel CEO buys 27.2K shares of common stock 01/21/21 Intel announces 5% increase to quarterly cash dividend 01/21/21 Intel up 7% after early release of Q4 results 01/17/21 Fly Intel: Top five weekend stock stories INTC Intel $53.59 / -1.62 (-2.93%) 01/27/21 Truist AMD price target raised to $101 from $96 at Truist 01/25/21 Citi Citi opens 'positive catalyst watch' on AMD but keeps $13 price target 01/22/21 Jefferies Intel has 'no easy or quick fix,' says Jefferies 01/22/21 Truist Intel price target raised to $64 from $60 at Truist INTC Intel $53.59 / -1.62 (-2.93%) 01/21/21 Intel sees Q1 EPS $1.10, consensus 93c 01/21/21 Intel reports Q4 EPS $1.52, consensus $1.10 01/21/21 Notable companies reporting after market close 01/13/21 Intel sees Q4 revenue and EPS to exceed prior guidance INTC Intel $53.59 / -1.62 (-2.93%) 01/27/21 TSMC reaches deal to make 3nm chips for Intel, DigiTimes reports 01/21/21 Intel says hacker gained access to financially sensitive data, FT reports 01/17/21 Trump admin slams China's Huawei, halting shipments from Intel, Reuters says 01/16/21 Intel rebound will still take time, Barron's says INTC Intel $53.59 / -1.62 (-2.93%) 01/22/21 Fly Intel: Wall Street's top stories for Friday 01/22/21 Fly Intel: Wall Street's top stories at midday 01/22/21 Fly Intel: Pre-market Movers 01/21/21 Fly Intel: What to watch in Intel's earnings report 04/22/21 Intel - INTC INTC Intel $53.59 / -1.62 (-2.93%) 01/22/21 Notable open interest changes for January 22nd 01/21/21 Intel options imply 9.0% move in share price post-earnings 01/13/21 Early notable gainers among liquid option names on January 13th 01/13/21 Intel call volume above normal and directionally bullish
Downgrade	Tesla downgraded to Market Perform at JMP Securities on valuation » 06:18 01/28/21 01/28 06:18 01/28/21 06:18 TSLA Tesla $864.66 / -18.83 (-2.13%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options TSLA Tesla $864.66 / -18.83 (-2.13%) 01/27/21 Tesla CEO says focused on execution, continues to build 'a lot of new capacity' 01/27/21 Tesla CFO says company achieved 6 consecutive quarters of net profit 01/27/21 Tesla sees 50% average annual growth in vehicle deliveries, faster in 2021 01/27/21 Tesla down $50.26, or 6%, to $813.90 after Q4 report TSLA Tesla $864.66 / -18.83 (-2.13%) 05:26 Today JMP Securities Tesla downgraded to Market Perform from Outperform at JMP Securities 01/27/21 Roth Capital Positive results 'clearly' priced into Tesla stock, says Roth Capital 01/27/21 Credit Suisse Positive deliveries guide could be catalyst for Tesla stock, says Credit Suisse 01/26/21 Credit Suisse Credit Suisse could see software, battery as key underpinnings of Apple car TSLA Tesla $864.66 / -18.83 (-2.13%) 01/27/21 Tesla reports Q4 non-GAAP EPS 80c, consensus $1.01 01/27/21 Notable companies reporting after market close 10/21/20 Tesla reports Q3 non-GAAP EPS 76c, consensus 56c 10/21/20 Notable companies reporting after market close 14 Feb TSLA Tesla $864.66 / -18.83 (-2.13%) 01/25/21 Tesla accuses engineer of stealing trade secrets, Business Insider reports 01/22/21 Waymo CEO: Tesla Autopilot will fall short of full autonomy, Bloomberg reports 01/21/21 Tesla's Q4 California registrations inccrease 63%, Reuters reports 01/20/21 Tesla lowers Model 3 prices in Europe, Electrek reports TSLA Tesla $864.66 / -18.83 (-2.13%) 01/27/21 Fly Intel: After-Hours Movers 01/27/21 Nokia soars but company 'not aware' of apparent reason for trading activity 01/27/21 Fly Intel: What to watch in Tesla earnings report 01/25/21 Walmart downgrade, Alibaba initiation among today's top calls on Wall Street TSLA Tesla $864.66 / -18.83 (-2.13%) 01/27/21 Tesla options imply 13.3% move in share price post-earnings 01/20/21 Notable open interest changes for January 20th 01/13/21 Notable open interest changes for January 13th 01/12/21 Notable open interest changes for January 12th

Earnings	Tractor Supply sees FY21 diluted EPS $6.50-$6.90, consensus $6.52 » 06:18 01/28/21 01/28 06:18 01/28/21 06:18 TSCO Tractor Supply $153.95 / +2.11 (+1.39%) Sees FY21 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events TSCO Tractor Supply $153.95 / +2.11 (+1.39%) 06:16 Today Tractor Supply reports Q4 SSS up 27.3% 12/10/20 Tractor Supply appoints Noni Ellison as general counsel, corporate secretary 12/09/20 Tractor Supply reduced carbon emissions from facilities by 29% 12/07/20 Tractor Supply announces new distribution center in Ohio TSCO Tractor Supply $153.95 / +2.11 (+1.39%) 01/22/21 Baird Tractor Supply checks suggest strong finish to quarter, says Baird 01/21/21 RBC Capital Tractor Supply price target raised to $175 from $168 at RBC Capital 10/22/20 Baird Tractor Supply price target raised to $170 from $162 at Baird 10/22/20 Baird Tractor Supply results robust as company re-invests forward, says Baird TSCO Tractor Supply $153.95 / +2.11 (+1.39%) 06:15 Today Tractor Supply reports Q4 EPS $1.64, consensus $1.51 01/27/21 Notable companies reporting before tomorrow's open 01/27/21 Notable companies reporting before tomorrow's open 10/22/20 Tractor Supply sees Q4 EPS $1.37 - $1.47, consensus $1.34 TSCO Tractor Supply $153.95 / +2.11 (+1.39%) 10/22/20 Fly Intel: Pre-market Movers 10:00 Today Tractor Supply - TSCO
Recommendations	Apple growing 'twofold,' shares can trade higher in 2021, says Citi » 06:18 01/28/21 01/28 06:18 01/28/21 06:18 AAPL Apple $142.14 / -1.03 (-0.72%) Citi analyst Jim Suva… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options AAPL Apple $142.14 / -1.03 (-0.72%) 01/27/21 Apple says new Mac chip boosting line growth rate 01/27/21 Facebook says business and community were strong in Q4 01/27/21 Apple says Q1 results were strong in China 01/27/21 Apple says iPhone 12 Pro and Pro Max did especially well in Q1 AAPL Apple $142.14 / -1.03 (-0.72%) 01/26/21 Credit Suisse Credit Suisse could see software, battery as key underpinnings of Apple car 01/25/21 Morgan Stanley Morgan Stanley says market closer to recognizing Alphabet sum-of-the-parts value 01/25/21 Evercore ISI Evercore ISI raises Apple price target to $160, sees higher odds of car product 01/25/21 Raymond James Apple price target raised to $150 from $140 at Raymond James AAPL Apple $142.14 / -1.03 (-0.72%) 01/27/21 Apple reports Q1 EPS $1.70, consensus $1.41 01/27/21 Notable companies reporting after market close 10/29/20 Apple says Q4 results were ahead of expectations 10/29/20 Apple reports Q4 Services revenue $14.55B vs. $12.51B last year AAPL Apple $142.14 / -1.03 (-0.72%) 06:05 Today IDC estimates Apple shipped 90.1M phones during Q1, CNBC reports 01/27/21 Apple to accelerate production shift outside China, Nikkei Asia says 01/25/21 Apple sued in Italy over throttled iPhone 6 devices, TechCrunch says 01/23/21 Big tech stocks are back, Barron's says AAPL Apple $142.14 / -1.03 (-0.72%) 01/27/21 Fly Intel: After-Hours Movers 01/27/21 #SocialStocks: Eyes on Facebook ahead of Q4 results 01/27/21 Fly Intel: What to watch in Apple earnings report 01/27/21 Fly Intel: What to watch in Facebook earnings report 02/23/21 Apple, Inc. AAPL Apple $142.14 / -1.03 (-0.72%) 01/27/21 Apple options imply 10.6% move in share price post-earnings 01/26/21 Notable open interest changes for January 26th 01/25/21 Notable open interest changes for January 25th 01/22/21 Notable open interest changes for January 22nd
Syndicate	Seer 3.75M share Secondary priced at $67.00 » 06:17 01/28/21 01/28 06:17 01/28/21 06:17 SEER Seer $68.51 / -5.24 (-7.11%) The deal size was… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate On The Fly Events SEER Seer $68.51 / -5.24 (-7.11%) 01/11/21 Seer, Thermo Fisher sign commercial agreement for proteomics 01/11/21 Seer, Bruker sign commercial agreement for unbiased, deep proteomics SEER Seer $68.51 / -5.24 (-7.11%) 12/29/20 BofA BofA starts Seer with Neutral after 239% post-IPO rally 12/29/20 Fly Intel: Top five analyst calls 12/29/20 Cowen Seer initiated with an Outperform at Cowen 12/29/20 Morgan Stanley Seer initiated with an Equal Weight at Morgan Stanley 28 Jan 04 Dec SEER Seer $68.51 / -5.24 (-7.11%) 12/29/20 Fly Intel: Wall Street's top stories for Tuesday 12/29/20 Fly Intel: Wall Street's top stories at midday 12/06/20 Opening Day: Kinnate Biopharma soars in trading debut 03/01/21 41st Annual Healthcare Virtual Conference
Hot Stocks	Tractor Supply reports Q4 SSS up 27.3% » 06:16 01/28/21 01/28 06:16 01/28/21 06:16 TSCO Tractor Supply $153.95 / +2.11 (+1.39%) Comparable store sales… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events TSCO Tractor Supply $153.95 / +2.11 (+1.39%) 12/10/20 Tractor Supply appoints Noni Ellison as general counsel, corporate secretary 12/09/20 Tractor Supply reduced carbon emissions from facilities by 29% 12/07/20 Tractor Supply announces new distribution center in Ohio 10/22/20 Tractor Supply backs FY20 CapEx view $300M-$325M TSCO Tractor Supply $153.95 / +2.11 (+1.39%) 01/22/21 Baird Tractor Supply checks suggest strong finish to quarter, says Baird 01/21/21 RBC Capital Tractor Supply price target raised to $175 from $168 at RBC Capital 10/22/20 Baird Tractor Supply price target raised to $170 from $162 at Baird 10/22/20 Baird Tractor Supply results robust as company re-invests forward, says Baird TSCO Tractor Supply $153.95 / +2.11 (+1.39%) 06:15 Today Tractor Supply reports Q4 EPS $1.64, consensus $1.51 01/27/21 Notable companies reporting before tomorrow's open 01/27/21 Notable companies reporting before tomorrow's open 10/22/20 Tractor Supply sees Q4 EPS $1.37 - $1.47, consensus $1.34 TSCO Tractor Supply $153.95 / +2.11 (+1.39%) 10/22/20 Fly Intel: Pre-market Movers 10:00 Today Tractor Supply - TSCO
Syndicate	CureVac 5M share Secondary priced at $90.00 » 06:16 01/28/21 01/28 06:16 01/28/21 06:16 CVAC CureVac $94.40 / -4.5 (-4.55%) BofA, Jefferies and… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate Periodicals On The Fly Events Options CVAC CureVac $94.40 / -4.5 (-4.55%) 01/07/21 Bayer signs collaboration, services agreement with CureVac for COVID-19 vaccine 12/21/20 CureVac to vaccinate first participant in CVnCoV study in healthcare workers 12/17/20 European Commission concludes talks with Novavax to secure potential vaccine 12/14/20 CureVac enrolls first participant in study of mRNA vaccine candidate CVnCoV CVAC CureVac $94.40 / -4.5 (-4.55%) 01/07/21 Morgan Stanley CureVac COVID-19 deal provides 'sentiment boost' for Bayer, says Morgan Stanley 12/10/20 Credit Suisse CureVac downgraded to Underperform on rising valuation at Credit Suisse 12/10/20 Credit Suisse CureVac downgraded to Underperform from Neutral at Credit Suisse 11/02/20 Piper Sandler CureVac's positive vaccine data bodes well for Arcturus's ARCT-021, says Piper 28 Jan 14 Aug CVAC CureVac $94.40 / -4.5 (-4.55%) 01/06/21 CureVac, Bayer reach alliance deal over COVID-19 vaccine, Reuters says 09/04/20 Germany awards grant to CureVac to accelerate vaccine development, BI reports 09/03/20 Musk praised CureVac to German Economy Minister, Reuters reports CVAC CureVac $94.40 / -4.5 (-4.55%) 01/25/21 Fly Intel: After-Hours Movers 01/07/21 Fly Intel: Pre-market Movers 11/10/20 Fly Intel: Pre-market Movers 11/02/20 Fly Intel: Pre-market Movers 03/02/21 2021 London Global Healthcare Virtual Conference CVAC CureVac $94.40 / -4.5 (-4.55%) 12/03/20 Largest borrow rate increases among liquid names 09/29/20 Largest borrow rate increases among liquid names 09/15/20 Largest borrow rate increases among liquid names 09/11/20 Largest borrow rate increases among liquid names

Syndicate	ZIM Integrated 14.5M share IPO priced at $15.00 » 06:16 01/28/21 01/28 06:16 01/28/21 06:16 ZIM ZIM Integrated $0.00 / + (+0.00%) The deal size was reduced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Syndicate 28 Jan
Initiation	Whole Earth Brands initiated with a Buy at Roth Capital » 06:15 01/28/21 01/28 06:15 01/28/21 06:15 FREE Whole Earth Brands $11.79 / -0.83 (-6.58%) Roth Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings FREE Whole Earth Brands $11.79 / -0.83 (-6.58%) 12/17/20 Whole Earth Brands to acquire Wholesome Sweeteners for $180M in cash 11/10/20 Whole Earth Brands acquires Swerve for $80M 09/21/20 Whole Earth Brands CEO Albert Manzone appointed to board of directors 09/08/20 Whole Earth Brands announces $20M stock repurchase plan FREE Whole Earth Brands $11.79 / -0.83 (-6.58%) 12/14/20 DA Davidson Whole Earth Brands initiated with a Buy at DA Davidson 12/01/20 Fly Intel: Top five analyst initiations 12/01/20 Cantor Fitzgerald Whole Earth Brands initiated with an Overweight at Cantor Fitzgerald 11/30/20 Cantor Fitzgerald Whole Earth Brands initiated with an Overweight at Cantor Fitzgerald FREE Whole Earth Brands $11.79 / -0.83 (-6.58%) 11/16/20 Whole Earth Brands narrows 2020 revenue view $270M-$280M from $270M-$290M 11/16/20 Whole Earth Brands reports Q3 EPS (7c) vs. (9c) last year 08/14/20 Whole Earth Brands sees 2020 revenue $270M-$290M 08/14/20 Whole Earth Brands reports Q2 revenue $66.8M vs. $69M last year
Periodicals	UBS to split COO role, appoint transformation officer, Bloomberg reports » 06:15 01/28/21 01/28 06:15 01/28/21 06:15 UBS UBS $14.57 / -0.39 (-2.61%) UBS is splitting up its… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly UBS UBS $14.57 / -0.39 (-2.61%) 01/26/21 UBS to launch new 3-year buyback program of up to CHF 4B 01/26/21 UBS to resume repurchasing shares shortly after Q4 results 01/26/21 UBS 'met or exceeded' all growth, returns targets, CEO says 01/26/21 UBS intends to repurchase up to $1.1B of shares in Q1 UBS UBS $14.57 / -0.39 (-2.61%) 01/27/21 Barclays UBS price target raised to CHF 13.40 from CHF 12 at Barclays 01/27/21 Morgan Stanley UBS price target raised to CHF 15 from CHF 14 at Morgan Stanley 01/27/21 JPMorgan UBS price target raised to CHF 16 from CHF 15 at JPMorgan 01/27/21 Deutsche Bank UBS price target raised to CHF 13 from CHF 12 at Deutsche Bank UBS UBS $14.57 / -0.39 (-2.61%) 01/26/21 UBS reports Q4 EPS 46c, may not compare to two estimates 28c 10/20/20 UBS reports Q3 EPS 56c, may not compare to two estimates 24c UBS UBS $14.57 / -0.39 (-2.61%) 01/13/21 UniCredit considers Orcel, Thiam for CEO role, FT reports 01/12/21 UBS chairman backs CEO Ralph Hamers after probe, Bloomberg reports 12/11/20 State Street weighs strategic options for asset management unit, Bloomberg says 12/11/20 State Street weighs strategic options for asset management unit, Bloomberg says UBS UBS $14.57 / -0.39 (-2.61%) 10/20/20 Fly Intel: Pre-market Movers 09/11/20 The Intersection: Crypto and Wall Street This Week
Hot Stocks	Cleveland-Cliffs commits to reduce greenhouse gas emissions 25% by 2030 » 06:15 01/28/21 01/28 06:15 01/28/21 06:15 CLF Cleveland-Cliffs $15.69 / -0.16 (-1.01%) Cleveland-Cliffs has set… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options CLF Cleveland-Cliffs $15.69 / -0.16 (-1.01%) 12/09/20 ArcelorMittal completes sale of ArcelorMittal USA to Cleveland-Cliffs 11/25/20 Cleveland-Cliffs receives antitrust clearance for ArcelorMittal USA acquisition 10/23/20 Cleveland-Cliffs still expects to be free cash flow positive in 2H 10/23/20 Cleveland-Cliffs expects to close acquisition of ArcelorMittal USA by year-end CLF Cleveland-Cliffs $15.69 / -0.16 (-1.01%) 01/26/21 GLJ Research Cleveland-Cliffs downgraded to Hold on 'emerging headwinds' at GLJ Research 01/26/21 GLJ Research Cleveland-Cliffs downgraded to Hold from Buy at GLJ Research 01/18/21 Exane BNP Paribas Cleveland-Cliffs upgraded to Outperform from Neutral at Exane BNP Paribas 01/12/21 B. Riley Securities Cleveland-Cliffs price target raised to $20 from $16 at B. Riley Securities CLF Cleveland-Cliffs $15.69 / -0.16 (-1.01%) 01/25/21 Cleveland-Cliffs sees Q4 revenues $2.2B-$2.4B, consensus $1.82B 10/23/20 Cleveland-Cliffs reports Q3 EPS (2c), consensus (10c) 09/28/20 Cleveland-Cliffs expects ArcelorMittal USA acquisition to be EPS accretive 07/30/20 Cleveland-Cliffs reports Q2 EPS (31c), consensus (50c) CLF Cleveland-Cliffs $15.69 / -0.16 (-1.01%) 08/27/20 Nucor, US Steel raise sheet prices by $40/st, Argus says CLF Cleveland-Cliffs $15.69 / -0.16 (-1.01%) 09/28/20 Fly Intel: Wall Street's top stories for Monday 09/28/20 Fly Intel: Wall Street's top stories at midday 09/28/20 Fly Intel: Pre-market Movers 02/09/21 42nd Annual Aerospace/Defense & Industrials Virtual Conference 02/25/21 Cleveland-Cliffs - CLF 05/11/21 Cleveland-Cliffs CLF Cleveland-Cliffs $15.69 / -0.16 (-1.01%) 01/15/21 Cleveland-Cliffs call volume above normal and directionally bullish 01/05/21 Cleveland-Cliffs call volume above normal and directionally bullish 12/28/20 Cleveland-Cliffs put volume heavy and directionally bearish 12/09/20 Cleveland-Cliffs call volume above normal and directionally bullish
Earnings	Tractor Supply reports Q4 EPS $1.64, consensus $1.51 » 06:15 01/28/21 01/28 06:15 01/28/21 06:15 TSCO Tractor Supply $153.95 / +2.11 (+1.39%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events TSCO Tractor Supply $153.95 / +2.11 (+1.39%) 12/10/20 Tractor Supply appoints Noni Ellison as general counsel, corporate secretary 12/09/20 Tractor Supply reduced carbon emissions from facilities by 29% 12/07/20 Tractor Supply announces new distribution center in Ohio 10/22/20 Tractor Supply backs FY20 CapEx view $300M-$325M TSCO Tractor Supply $153.95 / +2.11 (+1.39%) 01/22/21 Baird Tractor Supply checks suggest strong finish to quarter, says Baird 01/21/21 RBC Capital Tractor Supply price target raised to $175 from $168 at RBC Capital 10/22/20 Baird Tractor Supply price target raised to $170 from $162 at Baird 10/22/20 Baird Tractor Supply results robust as company re-invests forward, says Baird TSCO Tractor Supply $153.95 / +2.11 (+1.39%) 01/27/21 Notable companies reporting before tomorrow's open 01/27/21 Notable companies reporting before tomorrow's open 10/22/20 Tractor Supply sees Q4 EPS $1.37 - $1.47, consensus $1.34 10/22/20 Tractor Supply reports Q3 EPS $1.62, consensus $1.33 TSCO Tractor Supply $153.95 / +2.11 (+1.39%) 10/22/20 Fly Intel: Pre-market Movers 10:00 Today Tractor Supply - TSCO

Upgrade	Silgan Holdings double-upgraded to Buy at BofA on demand strength » 06:14 01/28/21 01/28 06:14 01/28/21 06:14 SLGN Silgan Holdings $35.87 / -0.42 (-1.16%) BofA analyst George… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings SLGN Silgan Holdings $35.87 / -0.42 (-1.16%) 01/26/21 Silgan Holdings jumps 3% to $37.45 after Q4 earnings beat 08/28/20 Silgan Holdings' Horrigan sells 800,000 common shares 08/28/20 Silgan Holdings' Snyder sells over 24,000 common shares SLGN Silgan Holdings $35.87 / -0.42 (-1.16%) 06:05 Today BofA Silgan Holdings upgraded to Buy from Underperform at BofA 01/07/21 Citi Silgan Holdings downgraded to Neutral from Buy at Citi 12/04/20 Wells Fargo Silgan Holdings upgraded to Overweight from Equal Weight at Wells Fargo 12/04/20 Wells Fargo Silgan Holdings upgraded to Overweight from Equal Weight at Wells Fargo SLGN Silgan Holdings $35.87 / -0.42 (-1.16%) 01/26/21 Silgan Holdings guides FY21 EPS $3.30-$3.45, consensus $3.08 01/26/21 Silgan Holdings reports Q4 EPS 60c, consensus 53c 10/21/20 Silgan Holdings raises FY20 adj. EPS view to $2.92-$2.97 from $2.70-$2.85 10/21/20 Silgan Holdings sees Q4 adj. EPS 47c-52c, consensus 49c
Syndicate	Qualtrics 50.4M share IPO priced at $30.00 » 06:14 01/28/21 01/28 06:14 01/28/21 06:14 XM Qualtrics $0.00 / + (+0.00%) The deal priced above the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Syndicate On The Fly 28 Jan XM Qualtrics $0.00 / + (+0.00%) 01/24/21 Opening Day: Mytheresa raises $407M in U.S. market debut 01/17/21 Opening Day: Poshmark surges in debut, PetCo soars in return to market 01/10/21 Opening Day: Cullinan, Gracell surge in debut as SPAC craze continues 12/29/20 Fly Intel: Pre-market Movers
Initiation	Monopar Therapeutics initiated with a Buy at Roth Capital » 06:14 01/28/21 01/28 06:14 01/28/21 06:14 MNPR Monopar Therapeutics $6.60 / -0.25 (-3.65%) Roth Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings MNPR Monopar Therapeutics $6.60 / -0.25 (-3.65%) 12/22/20 Monopar Therapeutics announces issuance of U.S. patent for camsirubicin analogs 12/10/20 Monopar Therapeutics, NorthStar announce selection of uPRIT candidate 12/08/20 Monopar Therapeutics intiates Phase 2b/3 trial of Validive 11/09/20 Monopar announces issuance of new patents for Validive MNPR Monopar Therapeutics $6.60 / -0.25 (-3.65%) 09/24/20 Maxim Monopar Therapeutics initiated with a Buy at Maxim 06/16/20 JonesTrading JonesTrading backs Buy on Monoper after NorthStar Medical collaboration 02/19/20 Brookline Monopar Therapeutics initiated with a Buy at Brookline 02/03/20 JonesTrading Monopar Therapeutics initiated with a Buy at JonesTrading MNPR Monopar Therapeutics $6.60 / -0.25 (-3.65%) 11/12/20 Monopar Therapeutics reports Q3 EPS (15c), consensus (15c)
Hot Stocks	New York Times names Cliff Levy to oversee audio unit » 06:12 01/28/21 01/28 06:12 01/28/21 06:12 NYT New York Times $55.00 / -1.285 (-2.28%) The New York Times… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events NYT New York Times $55.00 / -1.285 (-2.28%) 01/19/21 Wright's Media announces collaboration with New York Times' Wirecutter 11/17/20 New York Times appoints Jacqueline Welch as EVP, CHRO 11/05/20 New York Times sees Q4 total subscription revenues up 14% 10/13/20 New York Times reduces pension obligations by $235M NYT New York Times $55.00 / -1.285 (-2.28%) 11/09/20 Evercore ISI New York Times upgraded to Outperform from In Line at Evercore ISI 10/27/20 JPMorgan New York Times selloff brings attractive entry point, says JPMorgan 10/14/20 Fly Intel: Top five analyst initiations 10/14/20 Morgan Stanley New York Times initiated with an Overweight at Morgan Stanley NYT New York Times $55.00 / -1.285 (-2.28%) 11/05/20 New York Times reports Q3 adj. EPS 22c, consensus 11c 08/05/20 New York Times reports Q2 adj. EPS 18c, consensus 1c NYT New York Times $55.00 / -1.285 (-2.28%) 09/16/20 Facebook, New York Times partner on AR reporting project, Axios reports 08/20/20 More companies join fight against Apple App Store terms, WSJ says NYT New York Times $55.00 / -1.285 (-2.28%) 08/25/20 Game On: Apple-Epic legal spat continues as Microsoft's Spencer weighs in 02/04/21 New York Times - NYT
Recommendations	TherapeuticsMD price target lowered to $4 from $5 at H.C. Wainwright » 06:11 01/28/21 01/28 06:11 01/28/21 06:11 TXMD TherapeuticsMD $1.59 / +0.055 (+3.58%) H.C. Wainwright analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options TXMD TherapeuticsMD $1.59 / +0.055 (+3.58%) 11/09/20 TherapeuticsMD begins process to divest vitaCare Prescription Services 09/21/20 TherapeuticsMD, Knight announces Health Canada approval of BIJUVA 09/09/20 TherapeuticsMD announces patent updates for Annovera 08/25/20 TherapeuticsMD, Knight Therapeutics announce Health Canada approval of IMVEXXY TXMD TherapeuticsMD $1.59 / +0.055 (+3.58%) 08/07/20 Jefferies Jefferies downgrades 'show-me story' TherapeuticsMD to Underperform 08/07/20 Jefferies TherapeuticsMD downgraded to Underperform from Hold at Jefferies 05/19/20 Fly Intel: Top five analyst downgrades 05/19/20 JPMorgan TherapeuticsMD downgraded to Neutral on COVID disruptions at JPMorgan TXMD TherapeuticsMD $1.59 / +0.055 (+3.58%) 11/09/20 TherapeuticsMD reports Q3 EPS (12c) with items, consensus (14c) 09/25/20 TherapeuticsMD says on track to meet or exceed Q3 revenue consensus of $15.1M 08/06/20 TherapeuticsMD reports Q2 EPS (19c) with items, consensus (17c) 10 Nov TXMD TherapeuticsMD $1.59 / +0.055 (+3.58%) 08/07/20 FedEx named Best Idea among today's top calls on Wall Street 03/01/21 41st Annual Healthcare Virtual Conference TXMD TherapeuticsMD $1.59 / +0.055 (+3.58%) 10/27/20 Largest borrow rate increases among liquid names 10/06/20 Largest borrow rate increases among liquid names 09/16/20 Largest borrow rate increases among liquid names 08/12/20 Largest borrow rate increases among liquid names

Hot Stocks	United Therapeutics announces BREEZE study of Tyvaso meets primary endpoint » 06:11 01/28/21 01/28 06:11 01/28/21 06:11 UTHR United Therapeutics $155.89 / -8.96 (-5.44%) United Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings UTHR United Therapeutics $155.89 / -8.96 (-5.44%) 01/27/21 3D Systems to expand efforts on regenerative medicine, bioprinting solutions 01/13/21 United Therapeutics: Results from INCREASE study of Tyvaso published in NEJM 12/28/20 Y-mAbs Therapeutics announces sale of priority review voucher 12/28/20 United Therapeutics to acquire PRV for Tyvaso DPI NDA UTHR United Therapeutics $155.89 / -8.96 (-5.44%) 01/20/21 Oppenheimer United Therapeutics price target raised to $200 from $175 at Oppenheimer 01/20/21 Cowen United Therapeutics price target raised to $200 from $160 at Cowen 01/20/21 Ladenburg United Therapeutics price target raised to $199 from $151 at Ladenburg 01/19/21 Credit Suisse Insmed price target raised to $60 from $50 at Credit Suisse UTHR United Therapeutics $155.89 / -8.96 (-5.44%) 10/28/20 United Therapeutics reports Q3 EPS $3.84, consensus $2.78 07/29/20 United Therapeutics reports Q2 EPS $3.68, consensus $2.86
Recommendations	VBL Therapeutics price target raised to $4 from $3 at H.C. Wainwright » 06:11 01/28/21 01/28 06:11 01/28/21 06:11 VBLT VBL Therapeutics / + H.C. Wainwright analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Earnings On The Fly Events VBLT VBL Therapeutics / + 01/27/21 VBL Therapeutics doses first patient in Phase 2 study of VB-201 01/15/21 VBL Therapeutics enters into share purchase agreement with Aspire Capital 12/29/20 VBL Therapeutics first patient for Oval Phase 3 study of VB-111 expansion 12/07/20 VBL Therapeutics chairman Bennett Shapiro purchases approx. 200K shares VBLT VBL Therapeutics / + 11/16/20 VBL Therapeutics reports Q3 EPS (12c), consensus (13c) 08/13/20 VBL Therapeutics reports Q2 EPS (14c), consensus (14c) VBLT VBL Therapeutics / + 12/30/20 Fly Intel: After-Hours Movers 08/13/20 Fly Intel: Pre-market Movers 03/15/21 33rd Annual Roth Virtual Conference
Upgrade	PTC upgraded to Outperform from Sector Perform at RBC Capital » 06:10 01/28/21 01/28 06:10 01/28/21 06:10 PTC PTC $121.12 / -8.44 (-6.51%) RBC Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events PTC PTC $121.12 / -8.44 (-6.51%) 12/14/20 PTC to acquire Arena Solutions for $715M in cash 11/10/20 PTC names Troy Richardson as COO 10/28/20 PTC, Rockwell Automation extend strategic alliance 09/08/20 Teradata promotes Hillary Ashton to chief product officer PTC PTC $121.12 / -8.44 (-6.51%) 05:29 Today RBC Capital PTC upgraded to Outperform from Sector Perform at RBC Capital 01/21/21 Barclays PTC price target raised to $142 from $130 at Barclays 01/12/21 Mizuho PTC price target raised to $150 from $130 at Mizuho 12/21/20 Deutsche Bank PTC price target raised to $132 from $120 at Deutsche Bank PTC PTC $121.12 / -8.44 (-6.51%) 01/27/21 PTC reports Q1 EPS 97c, consensus 65c 01/27/21 PTC raises FY21 non-GAAP EPS view to $2.65-$2.85 from $3.05-$3.25 12/16/20 PTC Q1 ARR tracking to midpoint of $1.28B-$1.32B guidance range 10/28/20 PTC sees FY21 non-GAAP EPS $2.65-$2.85, consensus $2.83 PTC PTC $121.12 / -8.44 (-6.51%) 01/27/21 Fly Intel: After-Hours Movers 12/09/20 JPMorgan downgrades Zoom, upgrades Autodesk in software ratings shakeup 07/29/20 Fly Intel: After-Hours Movers 02/10/21 PTC Inc
Hot Stocks	Murphy Oil sees FY21 production 155-165 MBOEPD » 06:10 01/28/21 01/28 06:10 01/28/21 06:10 MUR Murphy Oil $13.98 / +1.27 (+9.99%) Murphy is planning 2021… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options MUR Murphy Oil $13.98 / +1.27 (+9.99%) 11/05/20 Murphy Oil backs 2020 CapEx view $680M-$720M MUR Murphy Oil $13.98 / +1.27 (+9.99%) 01/14/21 Scotiabank Murphy Oil upgraded to Sector Perform from Underperform at Scotiabank 01/11/21 Mizuho Murphy Oil price target raised to $18 from $10 at Mizuho 12/15/20 Wells Fargo Wells Fargo says Buy Exxon Mobil, Sell Murphy Oil in Oil & Gas ratings shake-up 12/15/20 Wells Fargo Murphy Oil downgraded to Underweight from Equal Weight at Wells Fargo MUR Murphy Oil $13.98 / +1.27 (+9.99%) 06:08 Today Murphy Oil reports Q4 adjusted EPS (9c), consensus (7c) 11/05/20 Murphy Oil sees Q4 total net production 146-154 MBOEPD excluding NCI 11/05/20 Murphy Oil reports Q3 adjusted EPS (15c), consensus (17c) 08/06/20 Murphy Oil reports Q2 adjusted EPS (71c), consensus (94c) MUR Murphy Oil $13.98 / +1.27 (+9.99%) 12/11/20 Airline changes, another Tesla downgrade among today's top calls on Wall Street 03/01/21 26th Annual Energy Virtual Summit 09:00 Today Murphy Oil - MUR MUR Murphy Oil $13.98 / +1.27 (+9.99%) 01/26/21 Murphy Oil put volume heavy and directionally bearish 01/19/21 Early notable gainers among liquid option names on January 19th 12/10/20 Early notable gainers among liquid option names on December 10th 12/08/20 Early notable gainers among liquid option names on December 8th
Hot Stocks	Barnwell Industries reaches pact with MRMP shareholders to end potential proxy » 06:10 01/28/21 01/28 06:10 01/28/21 06:10 BRN Barnwell Industries $1.89 / -0.02 (-1.05%) Barnwell Industries is… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< On The Fly BRN Barnwell Industries $1.89 / -0.02 (-1.05%) 01/25/21 Fly Insider: OncoCyte, Air Transport among week's notable insider trades

Events

Earnings calls, analyst events, roadshows and more

MMYT
Today at 07:30

MakeMyTrip - MMYT Conference Calls
MIXT
Today at 08:00

MiX Telematics - MIXT Conference Calls
MKC
Today at 08:00

McCormick - MKC Conference Calls
WHR
Today at 08:00

Whirlpool - WHR Conference Calls
NURO
Today at 08:00

NeuroMetrix - NURO Conference Calls
SLM
Today at 08:00

Sallie Mae - SLM Conference Calls
LSTR
Today at 08:00

Landstar System - LSTR Conference Calls
DHR
Today at 08:00

Danaher - DHR Conference Calls
DOW
Today at 08:00

Dow Inc. - DOW Conference Calls
FLWS
Today at 08:00

1-800-Flowers.com - FLWS Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	EZGO X EZGO EZGO Technologies IPO Managers: Priced at: $4.00 2.8M Shares CRKN X CRKN Crown Electrokinetics Secondary Managers: Roth Capital, National Securities, Colliers Priced at: $4.50 4.15M Shares LPCN X LPCN Lipocine Spot Secondary Managers: Raymond James Priced at: $1.75 14.3M Shares SEEL X SEEL Seelos Therapeutics Spot Secondary Managers: BTIG Priced at: $2.05 15.244M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	SCPS X SCPS Scopus BioPharma IPO Managers: Benchmark, Joseph Gunnar Priced at: $9.00 1M Shares SHLS X SHLS Shoals Technologies IPO Managers: Goldman Sachs, JPMorgan, Guggenheim, UBS, Morgan Stanley, Barclays & Credit Suisse, Cowen, Oppenheimer Priced at: $25.00 77M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TIRX X TIRX Tian Ruixiang IPO Managers: Network 1 Financial Priced at: $4.00 3M Shares GRBK X GRBK Green Brick Secondary Managers: Barclays & Goldman Sachs Priced at: $20.95 6M Shares CBIO X CBIO Catalyst Biosciences Spot Secondary Managers: Piper Sandler, Raymond James Priced at: $5.75 8.7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DZSI X DZSI DZS Spot Secondary Managers: Stifel, Needham & B. Riley Securities Priced at: $14.00 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PLUG X PLUG Plug Power Spot Secondary Managers: Morgan Stanley Priced at: $65.00 28M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PSNL X PSNL Personalis Spot Secondary Managers: Morgan Stanley, BofA, Citi & Cowen Priced at: $38.00 3.95M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial QUMU X QUMU Qumu Spot Secondary Managers: Craig-Hallum Priced at: $6.75 3.225M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	AGFY X AGFY Agrify IPO Managers: Maxim & Roth Capital Priced at: $10.00 5.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial OCDX X OCDX Ortho Clinical IPO Managers: JPMorgan, BofA, Goldman Sachs, Barclays & Morgan Stanley, Citi, Credit Suisse, UBS, Evercore ISI, Piper Sandler, ING Bank, Macquarie, Nomura, TCG Capital Markets, Drexel Hamilton, H.C. Wainwright, Ramirez, Seibert Williams Priced at: $17.00 76M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VINP X VINP Vinci Partners Investments IPO Managers: JPMorgan, Goldman Sachs & BTG Pactual, Itau BBA, BofA, Credit Suisse, UBS Priced at: $18.00 13.873M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial XM X XM Qualtrics IPO Managers: Morgan Stanley & JPMorgan, BofA, Barclays, Deutsche Bank, Goldman Sachs, HSBC, Citi, BMO Capital, Truist, Canaccord, Evercore ISI, JPMorgan, Oppenheimer, Piper Sandler, Raymond James, William Blair, Loop Capital, RMRZ, SEEL Priced at: $30.00 50.4M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ZIM X ZIM ZIM Integrated IPO Managers: Citi, Goldman Sachs & Barclays, Jefferies, Clarksons Platou Priced at: $15.00 14.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ASO X ASO Academy Sports Secondary Managers: Credit Suisse, JPMorgan, KKR & BofA Priced at: $21.50 12M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CVAC X CVAC CureVac Secondary Managers: BofA, Jefferies & Evercore ISI, UBS, Guggenheim, Berenberg, Kempen & Co., Priced at: $90.00 5M Shares SEER X SEER Seer Secondary Managers: JPMorgan, Morgan Stanley, BofA & Cowen Priced at: $67.00 3.75M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	No deals
Fri	No deals

Mon	ERF X ERF Enerplus Spot Secondary Managers: RBC Capital & BMO Capital $3.37 28.75M Shares
Tues	No deals
Wed	SGRY X SGRY Surgery Partners Secondary Managers: JPMorgan & Jefferies, Barclays, KKR, Macquarie $31.30 6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SRGA X SRGA Surgalign Secondary Managers: Piper Sandler, Cantor Fitzgerald & BTIG, Craig-Hallum, Lake Street $2.11 25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AGTC X AGTC Applied Genetic Spot Secondary Managers: Stifel, Wells Fargo & MTS Health Partners $4.45 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PWFL X PWFL PowerFleet Spot Secondary Managers: Canaccord $8.01
Thurs	HMPT X HMPT Home Point Capital IPO Managers: Goldman Sachs, Wells Fargo, Morgan Stanley & UBS, Credit Suisse, JPMorgan, BofA, JMP Securities, Piper Sandler, Seelaus, SPC Capital, Wedbush, Zelman $19.00-21.00 12.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SEGR X SEGR Southeastern Grocers IPO Managers: BofA & Goldman Sachs, Deutsche Bank, BMO Capital, Truist, Wells Fargo $14.00-16.00 8.9M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TRIN X TRIN Trinity Capital IPO Managers: Keefe Bruyette, Wells Fargo & UBS, Janney Montgomery Scott, B. Riley Securities, Ladenburg, Compass Point $13.50-15.50 7.55M Shares CALT X CALT Calliditas Therapeutics Secondary Managers: Citi, Jefferies & Stifel, Kempen & Co.,, LifeSci Capital, Carnegie $31.20 4.5M Shares DCT X DCT Duck Creek Technologies Secondary Managers: Goldman Sachs, JPMorgan & BofA $52.85 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

Trump announces new actions intended to limit drug prices

TODAY'S FREE FLY STORIES

Get Full Fly Access